Product Information

TETRACYCLINE 250 MG CAPSULE is a generic product labeled by Amneal Pharmaceuticals NY LLC, priced at $0.2462 per EA under NDC 60219152201. Its NADAC has been published 198 times since Nov 9, 2022.

FDA first approved this application on Sep 18, 2018. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

TETRACYCLINE 250 MG CAPSULE

Tetracycline Hydrochloride
$0.2462per EA

Strength

250 mg/1

NDC

60219152201

Classification

Generic

Dosage Form

CAPSULE

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

TETRACYCLINE HYDROCHLORIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA210674

FDA Approved

9/18/2018

TE Code

AB

On Market Since

8/10/2022

Pharmacological Classes

Price Statistics

The NADAC for TETRACYCLINE 250 MG CAPSULE has been published 198 times since Nov 9, 2022, and over the history we have for it it has declined 65.5%. The table below summarizes its recorded NADAC range and movement.

Current price$0.2462 per EA
All-time high$1.0967 (Dec 13, 2023)
All-time low$0.2462 (Aug 19, 2026)
52-week high$0.7024
52-week low$0.2462
Median price$0.5869
Average price$0.5889
Largest weekly change+51.4% (Jun 21, 2023)
Weeks tracked198
Tracking sinceNov 9, 2022

Price History

1W

-3.5%

1M

-3.5%

3M

-16.1%

6M

-49.7%

1Y

-64.8%

3Y

-65.6%

5Y

N/A

All

-65.5%

Generic Alternatives

The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of TETRACYCLINE 250 MG CAPSULE?

The current National Average Drug Acquisition Cost (NADAC) for TETRACYCLINE 250 MG CAPSULE, manufactured by Amneal Pharmaceuticals NY LLC, is $0.2462 per EA (NDC 60219152201), effective Aug 19, 2026.

How has the price of TETRACYCLINE 250 MG CAPSULE changed over time?

Over the history we have for it, the NADAC for TETRACYCLINE 250 MG CAPSULE has declined 65.5%. It has been tracked across 198 weekly CMS publications since Nov 9, 2022.

What are the highest and lowest recorded NADAC prices for TETRACYCLINE 250 MG CAPSULE?

Since Nov 9, 2022, the NADAC for TETRACYCLINE 250 MG CAPSULE has ranged from a low of $0.2462 (Aug 19, 2026) to a high of $1.0967 (Dec 13, 2023), with a median of $0.5869 per EA.

Are there cheaper alternatives to TETRACYCLINE 250 MG CAPSULE?

4 manufacturers publish a NADAC-priced product with the same active ingredient and strength as TETRACYCLINE 250 MG CAPSULE in a comparable dosage form, but none are currently priced below it.

Who manufactures TETRACYCLINE 250 MG CAPSULE?

TETRACYCLINE 250 MG CAPSULE (NDC 60219152201) is labeled by Amneal Pharmaceuticals NY LLC, and CMS classifies it as a generic product.